Clinical trial
Reversal of Acute β-Blocker Induced Bronchoconstriction
NCT01070225 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversal of Acute β-Blocker Induced Bronchoconstriction
- Lead sponsor
- University of Dundee
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- October 31, 2010
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.